Cargando…
1例EGFR驱动基因阳性晚期肺癌患者的综合治疗
Lung cancer is the most common malignant tumor and the leading cause of cancer-related death worldwide. Most of the patients have distant metastasis when visiting the doctor, which seriously affects the survival time and quality of life of the patients. With the development of molecular targeted dru...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246388/ https://www.ncbi.nlm.nih.gov/pubmed/34157804 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.20 |
Ejemplares similares
-
晚期ALK融合阳性非小细胞肺癌治疗全程管理1例
Publicado: (2021) -
五次应用分子靶向药物治疗晚期肺癌患者1例
Publicado: (2013) -
吉西他滨治疗RRM1阴性晚期难治非小细胞肺癌患者1例
Publicado: (2011) -
复合性小细胞肺癌伴EGFR基因突变1例报道及治疗体会
Publicado: (2014) -
1例3次挑战培美曲塞方案治疗晚期非小细胞肺癌有效的个案报道
Publicado: (2019)